EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives

Lori M Minasian iD, Ann O'Mara, Sandra A Mitchell iD

Patient Related Outcome Measures · 2022-12 · Volume 13 · 249-258

DOI: 10.2147/prom.s256567 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Patient Related Outcome Measures, 2022-12. Verfasst von Lori M Minasian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PRO-CTCAEPatient-Reported Outcomes version of the Common Terminology Criteria for Advers…cancer therapypatient-reported outcomestolerabilitytoxicity

Autor:innen und Institutionen

  • Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
  • Consultant, ICF, Fairfax, VA, USA.
  • Consultant to Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
  • Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

ORCID-Profile: Lori M Minasian, Sandra A Mitchell

Zitieren

APA

Minasian, L. M., O'Mara, A., & Mitchell, S. A. (2022). Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives. Patient Related Outcome Measures, Volume 13, 249-258. https://doi.org/10.2147/prom.s256567

Vancouver

Minasian LM, O'Mara A, Mitchell SA. Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives. Patient Related Outcome Measures. 2022;Volume 13:249-258. doi:10.2147/prom.s256567

BibTeX
@article{Minasian2022,
  author = {Minasian, Lori M and O'Mara, Ann and Mitchell, Sandra A},
  title = {Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives},
  journal = {Patient Related Outcome Measures},
  year = {2022},
  volume = {Volume 13},
  pages = {249--258},
  doi = {10.2147/prom.s256567}
}
Kostenlos starten →